Role of the Clinical Pathology Laboratory
in the Evaluation of Lynch-Syndrome
Related Gynecological Cancers
Russell R. Broaddus, MD, PhD - University of Texas,
MD Anderson Cancer Clinic
Lynch syndrome increases the lifetime risk of endometrial cancer to 25% - 60% and ovarian cancer to 4 - 12%. Approxiamtely 30% of lynch syndrome related ovarian cancers are diagnosed before 40 years of age. While the importance of proper surveillance, chemoprevention, and risk-reducing surgeries are well known when constructing an appropriate care plan, often overlooked is the critical role of the clinical pathology laboratory in the evaluation of Lynch Syndrome-related gynecological cancers.
The "Gynecological Pathology in Lynch Syndrome" webinar will be a source of information for primary care physicians, surgeons, gastroenterologists, genetic counselors, and nurses and will include education on the following topics:
Immunohistochemistry for Mismatch Repair Proteins
Microsatellite Instability Analysis
MLH1 Promoter Methylation Analysis
Pitfalls in Test Interpretation
Discrepancies between Tissue Testing and Genetic Testing
Approaches to Screening for Lynch Syndrome-related Gynecological Cancers
Pathological features of Lynch Syndrome-related Gynecological Cancers
Implications of Pathology Reports as it Relates to Gynecological Prophyaxis
At the conclusion of this webinar series, medical professionals will be able to:
Communicate how pathology impacts the care plan for Lynch Syndrome
Summarize the pitfalls in test interpretation
Give examples of discrepancies between tissue testing and genetic testing
7 Part Webinar Series: $55* by February 20th
7 Part Webinar Series: $60* after February 20th
The National Society of Genetic Counselors (NSGC) has authorized the Hereditary Colon Cancer Foundation to offer up to 0.7 CEUs or 7.0 contact hours (Category 1) for Preparing to Treat Polyposis Conditions. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of certification and recertification.
*At the time of registration, a one time $25 fee will be added for the individual's application to the NSGC for CEUs.
Genetic Counselors may attend the sessions LIVE or wait for the On-Demand recorded webinars.
According to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), 3 hour(s) earned in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN.
Registration fees cover the cost of CEUs, production and promotion of the webinar series. Proceeds benefit the Hereditary Colon Cancer Foundation. If you would like to receive a refund, please email 24 hours prior to the first webinar(s) start time. Refunds will exclude a 10% processing fee.
Live: November 5, 2015 @ 1:00 p.m. EST
On Demand: November 9, 2015
ALL Webinars are available